Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prolonged survival of patients with peripheral T-cell lymphoma after first-line intensive sequential chemotherapy with autologous stem cell transplantation.
Prochazka V, Faber E, Raida L, Vondrakova J, Kucerova L, Jarosova M, Indrak K, Papajik T. Prochazka V, et al. Among authors: kucerova l. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009 Mar;153(1):63-6. doi: 10.5507/bp.2009.011. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009. PMID: 19365529 Free article.
Rituximab does not adversely affect the stem cell mobilization and engraftment after high-dose therapy and autologous transplantation in patients with diffuse large B-cell lymphoma in first complete or partial remission.
Papajik T, Pikalova Z, Raida L, Skoumalova I, Vondrakova J, Faber E, Prochazka V, Kubova Z, Kucerova L, Pavlik T, Dusek L, Indrak K. Papajik T, et al. Among authors: kucerova l. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009 Sep;153(3):211-4. doi: 10.5507/bp.2009.035. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009. PMID: 19851434 Free article.
Long-term outcome of patients with peripheral T-cell lymphoma treated with first-line intensive chemotherapy followed by autologous stem cell transplantation.
Prochazka V, Faber E, Raida L, Papajik T, Vondrakova J, Rusinakova Z, Kucerova L, Myslivecek M, Indrak K. Prochazka V, et al. Among authors: kucerova l. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Mar;155(1):63-9. doi: 10.5507/bp.2011.009. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011. PMID: 21475380 Free article.
Precursor T-lymphoblastic lymphoma as a secondary malignancy in a young patient after successful treatment of acute promyelocytic leukemia.
Szotkowski T, Jarosova M, Faber E, Hubacek J, Hlusi A, Papajik T, Pikalova Z, Kucerova L, Holzerova M, Budikova M, Buriankova E, Plachy R, Potomkova J, Klusova N, Szotkowska R, Indrak K. Szotkowski T, et al. Among authors: kucerova l. Onkologie. 2009 Sep;32(8-9):513-5. doi: 10.1159/000226584. Epub 2009 Jul 23. Onkologie. 2009. PMID: 19745598
Standardised uptake value of 18F-FDG on staging PET/CT in newly diagnosed patients with different subtypes of non-Hodgkin's lymphoma.
Papajík T, Mysliveček M, Sedová Z, Buriánková E, Procházka V, Koranda P, Raida L, Kubová Z, Palová M, Kučerová L, Flodr P, Jarkovský J, Dušek L, Indrák K. Papajík T, et al. Among authors: kucerova l. Eur J Haematol. 2011 Jan;86(1):32-7. doi: 10.1111/j.1600-0609.2010.01532.x. Epub 2010 Nov 11. Eur J Haematol. 2011. PMID: 20874822 Clinical Trial.
228 results